FILE PHOTO: The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly/File Photo
- Pfizer Inc said on Tuesday it will invest up to $500 million into publicly traded drug developers to fund their treatment candidates and provide access to the U.S. drugmaker’s scientific expertise. Pfizer said it will make non-controlling investments in the biotechs with small- to medium-sized market capitalizations, but did not identify them.
The move comes at a time when the COVID-19 pandemic has led drugmakers to delay their clinical trials testing various therapies. Pfizer said its Breakthrough Growth Initiative program, under which it was making the investment, allows partner companies to access its research, clinical development and manufacturing resources.
That's nothing, they spend more than that on their drug pushers with all the lobbyists working the government!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer to invest up to $500 million in small and medium-sized biotech companiesPfizer Inc. said Tuesday it is planning to invest up to $500 million in biotech companies to support the sector's most promising clinical development programs. "There has never been a more important moment to pursue new collaborations in our industry," said John Young, Pfizer's chief business officer, as he unveiled the Pfizer Breakthrough Growth Initiative. The program will focus on small to medium-sized biotech company in the areas of internal medicine, inflammation and immunology, oncology, rare disease, vaccines and hospital. Pfizer shares rose 1.2% in premarket trade, but are down 9% in the year to date, while the S&P 500 has fallen 5% and the Dow Jones Industrial Average has fallen 11%. tradingdedaubes Tiens les aficionados de quantumgenomics vont reprendre la balle au rebond 😉
Source: MarketWatch - 🏆 3. / 97 Read more »
Pfizer to invest up to $500 million in small and medium-sized biotech companiesPfizer Inc. said Tuesday it is planning to invest up to $500 million in biotech companies to support the sector's most promising clinical development programs. "There has never been a more important moment to pursue new collaborations in our industry," said John Young, Pfizer's chief business officer, as he unveiled the Pfizer Breakthrough Growth Initiative. The program will focus on small to medium-sized biotech company in the areas of internal medicine, inflammation and immunology, oncology, rare disease, vaccines and hospital. Pfizer shares rose 1.2% in premarket trade, but are down 9% in the year to date, while the S&P 500 has fallen 5% and the Dow Jones Industrial Average has fallen 11%. tradingdedaubes Tiens les aficionados de quantumgenomics vont reprendre la balle au rebond 😉
Source: MarketWatch - 🏆 3. / 97 Read more »
Gilead trades that made millions on COVID-19 drug news raise eyebrowsWell-timed trades in Gilead Sciences Inc's options ahead of good news on the biopharmaceutical company's COVID-19 drug treatment may draw regulatory scrutiny, experts said. Scumbags SOLTARAM OS PRESOS PARA TOCAR O TERROR. ENTENDERAM AGORA ? Somos57MILHOES ¿Remdesivir... singing victory...? Not so soon......vaccines ready at all.......
Source: Reuters - 🏆 2. / 97 Read more »
US sends 2 million doses of unproven virus drug to BrazilThe United States has delivered two million doses of the antimalarial medicine hydroxychloroquine (HCQ) to Brazil to fight COVID-19, the White House said Sunday, though the drug has not been proven effective against the coronavirus. It said the US would soon also send 1,000 ventilators to Brazil, the So you don't care for Brazilian lives...........
Source: YahooNews - 🏆 380. / 59 Read more »
Russians claim to have an effective treatment for the coronavirus, which hospitals will start using in JuneRussia has approved an anti-influenza drug to treat Covid-19 and will start delivering courses of the drug, Avifavir, to hospitals in June, according to Russia's sovereign wealth fund (RDIF). Let’s make Trump try it first Yeah fucking right eating plutonium doesn't count
Source: CNBC - 🏆 12. / 72 Read more »